RxDoctor Payments Data

Terri Anderson

Family · Uniontown, PANPI 1255769626

Payments from drug & device makers

$4,374in general payments, 2019–2025

Across 271 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$764
  • Pfizer$618
  • Merck$440
  • Boehringer Ingelheim$409
  • Novartis$368
  • AstraZeneca$318
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$4,360100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,374 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$55,142
Medicare patients
330
Services billed
646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban248$238,982
EntrestoSacubitril/Valsartan100$136,023
XareltoRivaroxaban62$68,925
JardianceEmpagliflozin66$66,272
Repatha SureclickEvolocumab25$29,090
FarxigaDapagliflozin Propanediol11$16,441
Icosapent Ethyl25$13,931
VascepaIcosapent Ethyl12$11,818
Dofetilide16$5,003
Metoprolol Succinate331$4,111
Diltiazem 24hr Er (Cd)Diltiazem Hcl85$2,715
Flecainide Acetate47$2,524
Atorvastatin Calcium237$2,347
Carvedilol254$2,085
Rosuvastatin Calcium112$2,079

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$618$238,982248 claims
NovartisEntresto$368$136,023100 claims
Johnson & JohnsonXarelto$764$68,92562 claims
Boehringer IngelheimJardiance$409$66,27266 claims
AstraZenecaFarxiga$318$16,44111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,717 family providers in Pennsylvania.

Other family in Uniontown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →